Meeting the Need: How Innovative Research & Development Models are Driving Global Contraceptive Access
A Stagnating Industry One of the core realities of contraceptive research & development (R&D) is that many promising products never make it to market. Some stall in early development and others face barriers during clinical trials, regulatory review, or introduction. Developing a new or improved contraceptive is a risky, expensive, and time-consuming process, complicated by: Scientific and biological challenges : Human reproduction is complex and controlling a drug’s systemic impact while...
